Phase II Study of BCMA Chimeric Antigen Receptor T-Cell Therapy in Patients With Newly Diagnosed Multiple Myeloma Ineligible for or Not Proceeding to Autologous Stem-Cell Transplantation (CAREMM-001) ...

OMAHA-004: Phase 3 trial of CYP11A1 inhibitor opevesostat versus androgen receptor pathway inhibitor (ARPI) switch in participants with metastatic castration-resistant prostate cancer (mCRPC) after a ...

Add Yahoo as a preferred source to see more of our stories on Google. Jim Hilson said his prostate cancer had ‘remained stable’ after going on the trial A “search and destroy” treatment has been found ...

A new study released Tuesday found microplastics deep inside samples from 9 out of 10 patients with prostate cancer, with more microplastic levels inside tumors than in regular healthy tissue nearby.

This week, cancer researchers in New York are one step closer to answering a question that has plagued medical and environmental advocates for decades: What is the role of plastic exposure in the ...

In a new study, researchers found microplastics deep inside prostate cancer tumors, raising more questions about the role the ubiquitous pollutants play in public health. Subscribe to read this story ...

Please provide your email address to receive an email when new articles are posted on . Microplastics can be found in prostate cancer tumors. Prostate tumor samples had a higher concentration of ...

Imperial College London investigators compared focal therapy with prostate removal surgery for men with prostate cancer that returned after radiotherapy. Matched analyses estimated 10-year ...

Eric Forrest, best known for his time with Voivod and his ongoing work fronting E-Force, has gone public with his battle against prostate cancer. Earlier today, the Toulouse, France–based vocalist and ...

Thirty-eight years ago, I was initiated into the oldest and one of the largest Black fraternities in the world: Alpha Phi Alpha Fraternity, Inc. It was one of the happiest days of my life. In ...

In a population-based cohort study, a single prostate-specific antigen (PSA) measurement in men aged 45-70 years effectively identified individuals with low risk for cancer. Men with PSA levels < 1.00 ...